Loading data for EIS — first visit, this takes a few seconds.
iShares MSCI Israel ETF (EIS)
NYSEArca: EIS
· 实时价格 · USD
122.73
-2.41 (-1.93%)
收盘价： Aug 31, 2026, 5:57 PM
iShares MSCI Israel ETF（EIS）ETF 价格、持仓与分析
| 买价 | 120 |
| 市值 | 无 |
| 管理资产规模（AUM） | 879.31M |
| 净值（NAV） | 125.38 |
| 贝塔（Beta） | 1.07 |
| 每股收益（EPS，过去十二个月） | 无 |
| 市盈率（PE，过去十二个月） | 17.79 |
| 流通股数 | 2.55M |
| 成立日期 | Mar 26, 2008 |
| 卖价 | 125.7 |
| 成交量 | 13,051 |
| 平均成交量（20日） | 67,871 |
| 开盘价 | 124.72 |
| 前收盘价 | 125.14 |
| 日内区间 | 123.02 - 124.73 |
| 52周区间 | 91.14 - 138.85 |
| 持仓 | 无 |
| 费用率 | 0.59% |
关于EIS
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index rhat is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Israel. The fund is non-diversified.
主要行业
| 行业 | 权重 % |
|---|---|
| Financial Services | 34.55% |
| Technology | 18.67% |
| Industrials | 10.83% |
| Healthcare | 10.55% |
| Real Estate | 8.35% |
前十大持仓 占资产的53.48%
| 名称 | 代码 | 权重 |
|---|---|---|
| Teva Pharmaceutical ... | TEVA | 10.1% |
| Bank Leumi Le-israel... | LUMI.TA | 8.66% |
| Bank Hapoalim Bm | POLI.TA | 7.86% |
| Tower Semiconductor ... | TSEM.TA | 6.12% |
| Elbit Systems Ltd | ESLT.TA | 5.57% |
| Phoenix Financial Lt... | PHOE.TA | 3.17% |
| Israel Discount Bank... | DSCT.TA | 3.16% |
| Nova Ltd | NVMI | 3.03% |
| Enlight Renewable En... | ENLT.TA | 2.93% |
| Mizrahi Tefahot Bank... | MZTF.TA | 2.88% |
分红 分红收益率 1.52%
| 除息日 | 金额 | 支付日期 |
|---|---|---|
| Jun 15, 2026 | $0.7720 | 无 |
| Dec 16, 2025 | $1.0890 | 无 |
| Jun 16, 2025 | $0.4920 | 无 |
| Dec 17, 2024 | $0.5480 | 无 |
| Jun 11, 2024 | $0.5170 | 无 |
9月前 · Investor's Business Daily
Israel Has Been Mired In Controversy During Its War With Hamas. Big Tech Investment Tells A Different Story.Israel's stock market has outpaced U.S. markets since Oct. 7, 2023, with U.S.-traded leaders like Teva, Elbit Systems and Tower Semiconductor showing big gains.